Abstract 1086: HER2 expression in circulating tumor cells as a minimally invasive biomarker of therapeutic response to trastuzumab deruxutecan in breast cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: National Cancer Center Hospital East, Sysmex (Japan)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148799416
Cites:
Cited by:
Related to:
